Exploring iDose® TR: The Future of Glaucoma Management thumbnail

Exploring iDose® TR: The Future of Glaucoma Management

Published Nov 28, 24
1 min read


iDose® TR represents a revolutionary advancement in the treatment of glaucoma, providing a sustained and effective solution for managing intraocular pressure (IOP). Unlike traditional eye drops that demand frequent use, iDose® TR is a tiny, implantable device crafted to provide a controlled release of medication directly into the eye over an prolonged period. This cutting-edge approach reduces the burden of constant dosing, greatly enhancing patient adherence and overall treatment results.

At Eye Center South, we are honored to introduce iDose® TR as part of our all-encompassing glaucoma care. The device is implanted during a gentle procedure, ensuring patient comfort and convenience. Once in place, it delivers a steady dose of the prescribed medication, helping to maintain stable IOP levels and protect your vision. Patients who have difficulty managing the routine of applying eye drops daily can experience significant advantages from this cutting-edge treatment.



Visit for more info At Eye Center South